Rimeporide in patients with Duchenne Muscular Dystrophy
A phase Ib, open label study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending oral doses of Rimeporide in patients with Duchenne Muscular Dystrophy. - Rim4DMD A phase Ib, open label study to evaluate the safety, tolerability, pharmacokinetics and pharmacodyna ...